檢索結果 - Michael C. Heinrich

Refine Results
  1. 1
    Dynamic sorting of lipids and proteins in membrane tubes with a moving phase boundary

    Dynamic sorting of lipids and proteins in membrane tubes with a moving phase boundary 由 Michael C. Heinrich, Aiwei Tian, Cinzia Esposito, Tobias Baumgart

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

    Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors 由 Ann W. Gramza, Christopher L. Corless, Michael C. Heinrich

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Translational insights into gastrointestinal stromal tumor and current clinical advances

    Translational insights into gastrointestinal stromal tumor and current clinical advances 由 Matthew L. Hemming, Michael C. Heinrich, Sebastian Bauer, Suzanne George

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor

    Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor 由 Sebastian Bauer, Suzanne George, Margaret von Mehren, Michael C. Heinrich

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Paraganglioma of the Head and Neck: A Review

    Paraganglioma of the Head and Neck: A Review 由 Lyndsey Sandow, Rajat Thawani, Myung‐Sun Kim, Michael C. Heinrich

    出版 2022
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Q<i>uadruple</i> wild‐type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways

    Q<i>uadruple</i> wild‐type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways 由 Maria A. Pantaleo, Margherita Nannini, Christopher L. Corless, Michael C. Heinrich

    出版 2014
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  7. 7
    Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach

    Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach 由 Robert J. Coffey, M. Kay Washington, Christopher L. Corless, Michael C. Heinrich

    出版 2007
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size

    KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size 由 Christopher L. Corless, Laura McGreevey, Andrea Haley, Ajia Town, Michael C. Heinrich

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms 由 Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors 由 Michael C. Heinrich, Diana Griffith, Arin McKinley, Janice Patterson, Ajia Presnell, Abhijit Ramachandran, Maria Dębiec‐Rychter

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit

    Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit 由 Anne E. Rader, Anne C. Avery, Cecily L. Wait, Laura McGreevey, Douglas O. Faigel, Michael C. Heinrich

    出版 2001
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping

    Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping 由 Carol Beadling, Tanaya Neff, Michael C. Heinrich, Katherine Rhodes, Michael Thornton, John H. Leamon, Mark T. Andersen, Christopher L. Corless

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

    BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance 由 Gerald S. Falchook, Jonathan C. Trent, Michael C. Heinrich, Carol Beadling, J. W. Patterson, Christel C. Bastida, S Blackman, Razelle Kurzrock

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia

    Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia 由 Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Katharina Henriette Rasp, Barbara Illing, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells

    The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells 由 Maureen E. Hoatlin, Tracy A. Christianson, Winnie W. Keeble, Adam T. Hammond, Yu Zhi, Michael C. Heinrich, Paula A. Tower, Grover C. Bagby

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

    Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells 由 Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell, Ajia Town, Laura McGreevey, Troy Bainbridge, Julie M. Cherrington, Michael C. Heinrich

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Heterogeneity of kinase inhibitor resistance mechanisms in GIST

    Heterogeneity of kinase inhibitor resistance mechanisms in GIST 由 Bernadette Liegl, Ilana Kepten, Claudia Le, Mei‐Jun Zhu, George D. Demetri, Michael C. Heinrich, CDM Fletcher, Christopher L. Corless, JA Fletcher

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors

    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progressio... 由 Katherine A. Janeway, Bernadette Liegl, Amy Harlow, Claudia Le, Antonio R. Pérez‐Atayde, Harry Kozakewich, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast

    High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast 由 Megan L. Troxell, Judith Levine, Carol Beadling, Andrea Warrick, Jennifer Dunlap, Ajia Presnell, Janice Patterson, Arielle Shukla, Neal Olson, Michael C. Heinrich, Christopher L. Corless

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

    SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase 由 Kevin Yee, A O’Farrell, Beverly D. Smolich, Julie M. Cherrington, Gerald McMahon, Cecily L. Wait, Laura McGreevey, Diana Griffith, Michael C. Heinrich

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: